Dental business remains strong despite medical softness
Henry Schein’s dental business continues to show momentum, with growth in April and May.
The company’s medical sales were softer due to a weak respiratory illness season.
Excluding flu- and RSV-related diagnostics, medical growth was mid-single-digit. The company reaffirmed its $125 million net run-rate value creation goal for the end of the year.